Net income
-13 million USD
2025-07-01 – 2026-06-30
Fundies. English
ANAVEX LIFE SCIENCES CORP.
EDGAR110 filing records in this dataset, filed from 2005-12-29 to 2026-11-03. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 118 million USD Source
Exact value
118326000 USD
- Long-term debt including current maturities
- 265 USD Source
Exact value
265 USD
- Shares outstanding
- 92.7 million shares Source
Exact value
92696842 shares
Reported share-count change
8.53% · 7.29 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Operating cash flow
-29.3 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: -39044000 USD · 2024-10-01 – 2025-09-30 Source
- Operating cash flow: -30440000 USD · 2024-10-01 – 2025-06-30 Source
- Operating cash flow: -7151000 USD · 2025-10-01 – 2025-12-31 Source
- Operating cash flow: -11591000 USD · 2025-10-01 – 2026-03-31 Source
- Operating cash flow: -7151000 USD · 2025-10-01 – 2025-12-31 Source
- Operating cash flow: -20687000 USD · 2025-10-01 – 2026-06-30 Source
- Operating cash flow: -11591000 USD · 2025-10-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-03.
Financial data available through: 2025-09-30.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 6 of 11 periods available· newest 2025-09-30
- Net income: 11 of 11 periods available· newest 2025-09-30
- Operating cash flow: 11 of 11 periods available· newest 2025-09-30
- capital expenditure: No compatible figures in this window
- Total assets: 11 of 11 periods available· newest 2025-09-30
- Total liabilities: 10 of 11 periods available· newest 2025-09-30
- Current assets: 5 of 11 periods available· newest 2019-09-30
- Current liabilities: 7 of 11 periods available· newest 2021-09-30
- Cash and cash equivalents: 10 of 11 periods available· newest 2025-09-30
- Long-term debt including current maturities: 1 of 11 periods available· newest 2015-09-30
- Shares outstanding: 11 of 11 periods available· newest 2025-09-30
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−USD 3.38 millionPrior period
−USD 43 million
–
Current period
−USD 46.38 million
–
Exact inputs and evidence
-46377000 − -43002000 = -3375000 USD
-43002000 USD · 2023-10-01 – 2024-09-30
Inspect prior input Prior source-46377000 USD · 2024-10-01 – 2025-09-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 8.23 millionPrior period
−USD 30.81 million
–
Current period
−USD 39.04 million
–
Exact inputs and evidence
-39044000 − -30812000 = -8232000 USD
-30812000 USD · 2023-10-01 – 2024-09-30
Inspect prior input Prior source-39044000 USD · 2024-10-01 – 2025-09-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2015-10-01 – 2016-09-30 | −USD 14.74 million Exact valueExact value: -14736698 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.24 million Exact valueExact value: -9236823 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2016-10-01 – 2017-09-30 | −USD 13.46 million Exact valueExact value: -13460405 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.02 million Exact valueExact value: -9017231 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2017-10-01 – 2018-09-30 | −USD 17.25 million Exact valueExact value: -17252736 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.58 million Exact valueExact value: -12582406 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-10-01 – 2019-09-30 | −USD 26.29 million Exact valueExact value: -26294979 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.53 million Exact valueExact value: -18527117 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2019-10-01 – 2020-09-30 | −USD 26.28 million Exact valueExact value: -26280470 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 21.29 million Exact valueExact value: -21287046 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-10-01 – 2021-09-30 | −USD 37.91 million Exact valueExact value: -37909000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 30.38 million Exact valueExact value: -30384000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-10-01 – 2022-09-30 | −USD 47.98 million Exact valueExact value: -47978000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 24.24 million Exact valueExact value: -24238000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-10-01 – 2023-09-30 | −USD 47.51 million Exact valueExact value: -47505000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 27.79 million Exact valueExact value: -27785000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2023-10-01 – 2024-09-30 | −USD 43 million Exact valueExact value: -43002000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 30.81 million Exact valueExact value: -30812000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-10-01 – 2025-09-30 | −USD 46.38 million Exact valueExact value: -46377000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 39.04 million Exact valueExact value: -39044000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
110 filings · 2,723 latest values · 2,723 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001314052, 1314052, AVXL, avxl, edgar:1314052
Also known as ANAVEX LIFE SCIENCES CORP., Thrifty Printing Inc.